shengnuo biotechnology participated in the 3rd China Peptide Industry Conference and the Peptide Branch of China Biochemical Industry Association

Chengdu Shengnuo Biotech

From September 20 to September 22, 2023, the second membership meeting of the Peptide Branch of the China Biochemical Pharmaceutical Industry Association and the third China Peptide Industry Conference were held in Shenzhen.

shengnuo biotechnology was invited to participate in two conferences, gathering together with relevant national drug supervision and inspection agencies, experts, scholars, and entrepreneurs in the field of peptides to conduct discussions and research around innovative applications and sustainable development of the peptide industry, and to help the healthy development of my country’s peptide industry.

The Second General Meeting of Peptide Branch of China Biochemical Pharmaceutical Industry Association

On the afternoon of September 20, 2023, the second general meeting of the Peptide Branch of the China Biochemical Pharmaceutical Industry Association was successfully held in Shenzhen.

The conference focused on a number of topics, including a summary of the work of the past four years, the selection of members of the second council, future work plans of the council, and the issuance of letters of appointment to many experts.

At this conference, Wen Yongjun, chairman of Chengdu shengnuo biotechnology, was elected as the vice chairman of the board of directors of the second peptide branch of China Biochemical Pharmaceutical Industry Association, and was appointed as an expert member of the second peptide branch of China Biochemical Pharmaceutical Industry Association.

Wen Yongjun, Chairman of Chengdu shengnuo biotechnology, was elected to the China Biochemical Pharmaceutical Industry Association

Vice Chairman of the Second Peptide Branch Council

Wen Yongjun, Chairman of Chengdu shengnuo biotechnology

Elected as an expert committee member of the second peptide branch of China Biochemical Pharmaceutical Industry Association

The 3rd China Peptide Industry Conference

On September 21-22, 2023, the “3rd China Peptide Industry Conference” was held in Shenzhen, Guangdong.

This two-day conference is hosted by the China Biochemical Pharmaceutical Industry Association and hosted by the Peptide Branch of the China Biochemical Pharmaceutical Industry Association. There is a main venue and 2 sub-venues, covering cutting-edge research, quality standards, production processes, clinical applications and localization of the peptide industry, and exploring ways and countermeasures to promote the high-end growth of strategic emerging industries.

During the conference, a roadshow event on the transformation of industrial scientific and technological achievements was held to promote high-quality dialogue between scientific research experts and industry enterprises.

Relevant national drug regulatory and inspection agencies, experts, scholars and entrepreneurs in the field of peptides, as well as R&D, production and sales enterprises in the peptide industry and researchers from universities and scientific research institutes gathered together to focus on “Polypeptides: Innovative Applications, Sustainable Development” This theme of the conference will jointly provide suggestions for the development of my country’s peptide industry.

Wen Yongjun, Chairman of Chengdu shengnuo biotechnology

Participated in a roundtable discussion at the 3rd China Peptide Industry Conference

This conference received an enthusiastic response from the domestic peptide industry. More than 200 companies participated in the conference, and 48 exchange booths were set up during the same period. A total of more than 600 experts, scholars, university representatives and business representatives attended this meeting.

During the roundtable discussion on the development and future of peptide drugs at this conference, the chairman of shengnuo biotechnology had in-depth exchanges with a number of peptide experts and scholars to discuss the current development trends of the peptide industry, and hoped that the industry would combine academic research with corporate development needs. , gathering the strength of all walks of life to make suggestions for the healthy development of the industry.

Wen Yongjun, Chairman of Chengdu shengnuo biotechnology, at the 3rd China Peptide Industry Conference

The Second General Meeting of the Peptide Branch of China Biochemical Pharmaceutical Industry Association and the Third China Peptide Industry Conference not only provide a high-level academic exchange platform for researchers in the field of peptide science, but also provide a platform for my country and other countries around the world, academia and industry. to build an important bridge for further cooperation.

shengnuo biotechnology sincerely hopes that the Peptide Branch of China Biochemical Pharmaceutical Industry Association and the 3rd China Peptide Industry Conference can continue to play a leading role in the industry and make more contributions to the healthy and prosperous development of my country’s peptide science.